Routinely vaccinating adolescents against meningococcus: targeting transmission & disease
Open Access
- 4 March 2016
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Vaccines
- Vol. 15 (5), 641-658
- https://doi.org/10.1586/14760584.2016.1130628
Abstract
Adolescents have the highest rates of meningococcal carriage and transmission. Interrupting the adolescent habitat in order to reduce carriage and transmission within adolescents and to other age g...Keywords
Funding Information
- GlaxoSmithKline
This publication has 91 references indexed in Scilit:
- Meningococcal Polysaccharide A O -Acetylation Levels Do Not Impact the Immunogenicity of the Quadrivalent Meningococcal Tetanus Toxoid Conjugate Vaccine: Results from a Randomized, Controlled Phase III Study of Healthy Adults Aged 18 to 25 YearsClinical and Vaccine Immunology, 2013
- Meningococcal Serogroup A, C, W135 and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the NetherlandsPLOS ONE, 2013
- Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd ImmunityClinical Infectious Diseases, 2012
- Prevalence of Serum Bactericidal Antibody to Serogroup C Neisseria meningitidis in England a Decade after Vaccine IntroductionClinical and Vaccine Immunology, 2012
- Meningococcal disease in Asia: an under-recognized public health burdenEpidemiology and Infection, 2011
- Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd ImmunityClinical and Vaccine Immunology, 2010
- Meningococcal carriage and disease—Population biology and evolutionVaccine, 2009
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd ImmunityThe Journal of Infectious Diseases, 2008
- Patterns of antigenic diversity and the mechanisms that maintain themJournal of The Royal Society Interface, 2007
- No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and WalesThe Lancet Infectious Diseases, 2006